Prothena Corporation plc

NASDAQ:PRTA  
6.26
-0.21 (-3.25%)
7:33:30 PM EDT: $6.55 +0.29 (+4.63%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)336.94M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$6.95 Million
Adjusted EPS-$1.22
See more estimates
10-Day MA$6.34
50-Day MA$6.08
200-Day MA$12.12
See more pivots

Prothena Corporation plc Stock, NASDAQ:PRTA

77 Sir John Rogersons Quay, Grand Canal Docklands, Dublin, Dublin 2
Ireland
Phone: +353.1.236.2500
Number of Employees: 163

Description

Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm�s clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer�s disease, Parkinson�s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.